Patient's Anastrozole Compliance to Therapy Programme - PACT

Study identifier:1033GR/0002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A randomised in practice evaluation of the influence of patient's understanding of her disease and therapy on persistence and compliance to adjuvant therapy for post-menopausal hormone sensitive early breast cancer

Medical condition

Breast Cancer

Phase

-

Healthy volunteers

No

Study drug

Anastrozole

Sex

Female

Actual Enrollment

4923

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Oct 2006
Primary Completion Date: 01 Feb 2011
Study Completion Date: 01 Feb 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria